<DOC>
	<DOCNO>NCT01715311</DOCNO>
	<brief_summary>This study compare efficacy indacaterol versus placebo ( i.e. , rescue medication ) tiotropium patient Chronic Obstructive Pulmonary Disease ( COPD ) receive maintenance COPD medication least 12 month prior entry ( described hereafter `` maintenance naïve '' , see inclusion criterion ) .</brief_summary>
	<brief_title>Comparison Indacaterol With That Placebo 'Maintenance naïve ' Patients With COPD Using Blinded Tiotropium Active Control</brief_title>
	<detailed_description>The purpose provide efficacy data compare long-acting beta-2 agonist , indacaterol , short-acting rescue therapy maintenance-naive patient belong GOLD 2011 Groups A B .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Patients stable Chronic Obstructive Pulmonary Disease ( COPD ) Groups A B accord GOLD 2011 . Patients postbronchodilator Forced Expiratory Volume one second ( FEV1 ) ≥50 % &lt; 80 % predict normal , postbronchodilator FEV1/ Forced Vital Capacity ( FVC ) &lt; 0.7 Patients record receipt maintenance medication COPD . Patients mMRC dyspnea score ≥1 Visit 2 . Current exsmokers smoke history least 10 pack year . Patients achieve acceptable spirometry result runin , accordance American Thoracic Society ( ATS ) / European Respiratory Society ( ERS ) criteria acceptability repeatability . Patients 2 COPD exacerbation require treatment antibiotic , systemic steroid ( oral intravenous ) hospitalization 12 month prior Visit 1 . Patients respiratory tract infection . Patients require longterm oxygen therapy ( &gt; 12 hour day ) daily basis . Patients ) history asthma , b ) onset respiratory symptom prior age 40 year . Patients allergic rhinitis use H1antagonist intranasal corticosteroid intermittently . Treatment stable dose permit . Patients concomitant pulmonary disease ( e.g. , lung fibrosis , sarcoidosis , interstitial lung disorder , pulmonary hypertension ) active pulmonary tuberculosis Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>COPD</keyword>
	<keyword>Chronic obstructive pulmonary disease</keyword>
	<keyword>indacaterol</keyword>
	<keyword>tiotropium</keyword>
</DOC>